Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity

被引：0
|
作者：
Wu, Yan
Zhong, Zhaojing
Martomo, Stella
Lu, Dan
Zhang, Haifan
Polonskaya, Zhanna
Luna, Xenia
Zhang, Zhikai
Wang, Zhun
Liu, Leo
Patel, Jeegar
Tonra, James
Li, Henry
Witte, Larry
Waksal, Sam
Zhu, Zhenping
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4997
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses
    Cubas, Rafael
    Moskalenko, Marina
    Cheung, Jeanne
    Yang, Michelle
    McNamara, Erin
    Xiong, Huizhong
    Hoves, Sabine
    Ries, Carola H.
    Kim, Jeong
    Gould, Stephen
    JOURNAL OF IMMUNOLOGY, 2018, 201 (08): : 2273 - 2286
  • [42] Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model
    Golchin, Soheila
    Alimohammadi, Reza
    Nejad, Mohammad Rostami
    Jalali, Seyed Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 19866 - 19874
  • [43] Redirecting Chemotherapeutics to the Endoplasmic Reticulum Increases Tumor Immunogenicity and Potentiates Anti-PD-L1 Therapy
    Xiang, Yucheng
    Chen, Liqiang
    Liu, Chendong
    Yi, Xiaoli
    Li, Lian
    Huang, Yuan
    SMALL, 2022, 18 (06)
  • [44] Development of novel combination cancer immunotherapy using anti-PD-1 and anti-PD-L1 antibody
    Hasegawa, Hirotaka
    Sugiyama, Daisuke
    Kanda, Mitsuro
    Hayashi, Masamichi
    Tanaka, Chie
    Yamada, Suguru
    Nakayama, Goro
    Koike, Masahiko
    Nomoto, Shuji
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    Nishikawa, Hiroyoshi
    CANCER SCIENCE, 2021, 112 : 741 - 741
  • [45] Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1/TGFβRII agent: Current status
    Gameiro, Sofia R.
    Strauss, Julius
    Gulley, James L.
    Schlom, Jeffrey
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (13) : 1124 - 1134
  • [46] QLS31901, a novel bifunctional anti-PD-L1/TGF-ß fusion protein for treatment of solid tumors
    Jiang, Jiahua
    Han, Cuicui
    Chen, Qi
    Wu, Yun
    Yan, Xiaodan
    Cao, Ping
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies
    Philips, George K.
    Atkins, Michael
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 39 - 46
  • [48] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [49] Preclinical evaluation of KD033, a human anti-PD-L1/IL-15 bispecific protein, in human PD-1/PD-L1 transgenic C57/Bl6 mice with PD-L1 positive and negative tumors
    Martomo, S.
    Lu, D.
    Polonskaya, Z.
    Luna, X.
    Zhang, Z.
    Regev, G.
    Schueller, O.
    Patel, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S856 - S856
  • [50] IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity
    Bahri, Rajia
    Pateras, Ioannis S.
    D'Orlando, Orietta
    Goyeneche-Patino, Diego A.
    Campbell, Michelle
    Polansky, Julia K.
    Sandig, Hilary
    Papaioannou, Marilena
    Evangelou, Kostas
    Foukas, Periklis G.
    Gorgoulis, Vassilis G.
    Bulfone-Paus, Silvia
    ONCOIMMUNOLOGY, 2015, 4 (09): : 1 - 13
12345